The CD4+ cells also showed a mixed pattern, with higher CD226 (activation) and Tim-3 (inhibitory) expression and lower GITR (activation), CD223 and B7H5 (inhibitory) expression after secondary infection (Table 3). The gene discussed is TNFRSF18; the disease is infection.